Literature DB >> 26221294

The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study.

Dongfeng Wei1, Chenlong Lv2, Junying Zhang3, Dantao Peng4, Liangping Hu2, Zhanjun Zhang3, Yongyan Wang5.   

Abstract

OBJECTIVE: The purpose of this study was to explore the effects of Xueshuan Xinmai tablets (XXMT) for the treatment of cognition, brain activation in the rehabilitation period of ischemic stroke patients.
METHODS: 28 adults patients, aged 50-80 years, in the rehabilitation period of ischemic stroke were divided into XXMT treatment group and placebo control group. Patients received 3 months treatment (oral 0.8 g, 3 times per day). Before and after treatment, all patients were evaluated by a series of neuropsychological tests followed by resting-state functional magnetic resonance imaging (fMRI).
RESULTS: In the XXMT treatment group, the patients' episodic memory showed significant improvement. The resting-state fMRI analysis indicated that a significant decline in the fractional amplitude of low-frequency fluctuation value was observed in the bilateral middle cingulate gyrus.
CONCLUSIONS: Yiqi Huoxue effect under XXMT administration has a favorable mediation on episodic memory, consequently suppresses the activation of the cingulate gyrus in the rehabilitation period of ischemic stroke patients.

Entities:  

Keywords:  Chinese medicinal formula; Episodic memory; brain activation; post-stroke rehabilitation patients; resting-state fMRI

Year:  2015        PMID: 26221294      PMCID: PMC4509239     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  32 in total

Review 1.  The global stroke initiative.

Authors:  Ruth Bonita; Shanthi Mendis; Thomas Truelsen; Julien Bogousslavsky; James Toole; Frank Yatsu
Journal:  Lancet Neurol       Date:  2004-07       Impact factor: 44.182

2.  ERP and fMRI measures of visual spatial selective attention.

Authors:  G R Mangun; M H Buonocore; M Girelli; A P Jha
Journal:  Hum Brain Mapp       Date:  1998       Impact factor: 5.038

3.  Impaired error-monitoring function in people with Internet addiction disorder: an event-related fMRI study.

Authors:  Guangheng Dong; Yue Shen; Jie Huang; Xiaoxia Du
Journal:  Eur Addict Res       Date:  2013-03-23       Impact factor: 3.015

4.  Microinfarct pathology, dementia, and cognitive systems.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-01-06       Impact factor: 7.914

5.  Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study.

Authors:  C S Carter; A W MacDonald; L L Ross; V A Stenger
Journal:  Am J Psychiatry       Date:  2001-09       Impact factor: 18.112

6.  Does rejection hurt? An FMRI study of social exclusion.

Authors:  Naomi I Eisenberger; Matthew D Lieberman; Kipling D Williams
Journal:  Science       Date:  2003-10-10       Impact factor: 47.728

7.  Clock drawing in Alzheimer's disease. A novel measure of dementia severity.

Authors:  T Sunderland; J L Hill; A M Mellow; B A Lawlor; J Gundersheimer; P A Newhouse; J H Grafman
Journal:  J Am Geriatr Soc       Date:  1989-08       Impact factor: 5.562

Review 8.  Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?

Authors:  M Haris U Usman; Lawrence A Notaro; Rangadham Nagarakanti; Eric Brahin; Scott Dessain; Edward Gracely; Michael D Ezekowitz
Journal:  Am J Cardiol       Date:  2009-03-04       Impact factor: 2.778

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.

Authors:  Christopher L H Chen; Sherry H Y Young; Herminigildo H Gan; Rajinder Singh; Annabelle Y Lao; Alejandro C Baroque; Hui Meng Chang; John Harold B Hiyadan; Carlos L Chua; Joel M Advincula; Sombat Muengtaweepongsa; Bernard P L Chan; H Asita de Silva; Somchai Towanabut; Nijasri C Suwanwela; Niphon Poungvarin; Siwaporn Chankrachang; K S Lawrence Wong; Gaik Bee Eow; Jose C Navarro; Narayanaswamy Venketasubramanian; Chun Fan Lee; Marie-Germaine Bousser
Journal:  Stroke       Date:  2013-06-18       Impact factor: 7.914

View more
  2 in total

1.  A Two-Year Treatment of Amnestic Mild Cognitive Impairment using a Compound Chinese Medicine: A Placebo Controlled Randomized Trial.

Authors:  Junying Zhang; Zhen Liu; Huamin Zhang; Caishui Yang; He Li; Xin Li; Kewei Chen; Zhanjun Zhang
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

2.  Pilot and feasibility trials in traditional Chinese medicine: a literature review of current practice.

Authors:  Guowei Li; Darong Wu; Xuejiao Chen; Jie Zeng; Ziyi Li; Lehana Thabane
Journal:  Pilot Feasibility Stud       Date:  2020-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.